What is the management approach for esophageal varices based on the Japanese grading system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Japanese Grading System for Esophageal Varices

Understanding the Japanese Classification System

The Japanese grading system classifies esophageal varices using two primary parameters: Form (F) and Red Color signs (RC), which differ from the Western simplified small/large classification 1.

Form (F) Grading

  • F0: No varices detected 2
  • F1: Small, straight varices that are minimally elevated above the esophageal mucosal surface 2
  • F2: Moderately enlarged, tortuous varices occupying less than one-third of the esophageal lumen 2
  • F3: Large, coil-shaped varices occupying more than one-third of the esophageal lumen 2

Red Color (RC) Signs

  • RC0: No red color signs present 3
  • RC1: Mild red color signs 3
  • RC2: Prominent red color signs (red wale marks or red spots) 4, 3

High-risk varices in the Japanese system are defined as F2 or greater and/or RC2 or above 3.

Management Algorithm Based on Japanese Grading

F0 (No Varices)

  • Repeat EGD every 2-3 years in compensated cirrhosis 1
  • Repeat EGD annually in decompensated cirrhosis 1

F1 (Small Varices)

Without red color signs (RC0-1):

  • Repeat EGD every 1-2 years in compensated cirrhosis 1
  • Consider nonselective beta-blockers if decompensated cirrhosis is present 4

With prominent red color signs (RC2):

  • Initiate prophylactic treatment immediately with either nonselective beta-blockers (propranolol or nadolol) targeting heart rate 55-60 bpm, or endoscopic variceal ligation 4
  • Red color signs mandate treatment regardless of variceal size, as 80% of patients with cherry red spots experience variceal bleeding 4, 5

F2-F3 (Medium to Large Varices)

All patients require prophylactic treatment 1:

Treatment options include:

  • Nonselective beta-blockers (propranolol or nadolol) with target heart rate 55-60 bpm 4
  • Carvedilol as an alternative beta-blocker 4
  • Endoscopic variceal ligation (EVL) 1
  • Combination of nonselective beta-blockers plus EVL for enhanced protection 4

The presence of RC2 signs in F2-F3 varices indicates extremely high bleeding risk and warrants aggressive prophylaxis 4, 5.

Critical Clinical Pearls

Prognostic Factors

The Japanese system's strength lies in identifying three independent risk factors for hemorrhage 4:

  • Variceal size (F grade)
  • Red color signs (RC grade)
  • Degree of hepatic decompensation (Child-Pugh class)

Surveillance After Treatment

  • Following EVL, perform follow-up endoscopy at 1-6 months after variceal eradication, then every 6-12 months 4
  • Monitor heart rate targets and medication tolerance in patients on beta-blockers 4

Common Pitfalls

  • Do not dismiss F1 varices with RC2 signs as "low risk"—they require the same aggressive prophylaxis as large varices 4
  • The Japanese F1/F2/F3 system provides more granular risk stratification than the Western small/large dichotomy, but Western guidelines group F2 and F3 together for treatment purposes 1
  • Interobserver variability exists in grading varices endoscopically, with kappa values ranging from -0.025 to 0.975 6

Diagnostic Accuracy

Capsule endoscopy shows 92% sensitivity and 80% specificity for detecting high-risk varices (F2 and/or RC2) in Japanese patients, offering a potential alternative screening method 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Esophageal Varices with Red Color Signs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Upper GI Endoscopy in Oesophageal Varices

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.